Results 201 to 210 of about 25,585 (256)

Selective cTACE to a segment target hepatocellular carcinoma lesion during atezolizumab plus bevacizumab therapy achieving delayed hypovascularization and shrinkage of non-target intrahepatic lesions: a case report. [PDF]

Oxf Med Case Reports
Hara H, Matsumoto H, Yoshinaga A, Ishii H, Onodera K, Henta Y, Katsumata R, Fujii R, Yamamoto H, Ashikawa T, Sakaki K, Ito S, Asakawa T, Yoshino K, Sakita S.   +14 more
europepmc   +1 more source

Multi-modal direct LINAC parameter prediction for pancreatic VMAT: An optimization-free approach. [PDF]

Med Phys
Guan Z, Shimizu Y, Iwai T, Yoshimura M, Mizowaki T, Nakamura M.   +5 more
europepmc   +1 more source

Chimeric biohybrid nanovesicles induce immunogenic cell death for targeted and immune-potentiated glioblastoma therapy. [PDF]

Asian J Pharm Sci
Zhu X, Xing Y, Jin W, Geng H, Li F, Li Y, Zhang H, Wu C, Chen C, Wu Z.   +9 more
europepmc   +1 more source

Multidisciplinary Management of Common Bile Duct Metastasis from Rectal Cancer: A Case Report of Long-Term Disease Control and Literature Review. [PDF]

Surg Case Rep
Kikkawa Y, Kochi M, Tokumoto Y, Hiura Y, Shinohara M, Yamaguchi M, Sumi Y, Hamaoka M, Hotta R, Hattori T, Toyota K.   +10 more
europepmc   +1 more source

Efficacy of Second-Line Lenvatinib After Atezolizumab-Bevacizumab and Durvalumab-Tremelimumab in Unresectable Hepatocellular Carcinoma: Association with Prior Immunotherapy Response. [PDF]

Cancers (Basel)
Kuzuya T, Muto H, Tachi Y, Komura G, Nakano T, Tanaka H, Nakaoka K, Funasaka K, Nagasaka M, Miyahara R, Ohno E.   +10 more
europepmc   +1 more source

A Practical Adjunct for Resolving Valve Sizing Ambiguity in Bicuspid Aortic Valves During Balloon-Expandable TAVR. [PDF]

JACC Case Rep
Ko AHY, Chui ASF.
europepmc   +1 more source

Reduced Local Tumor Progression After Thermal Ablation During Atezolizumab Plus Bevacizumab Treatment for Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Nakabori T, Mukai K, Miyanaga T, Takiyama H, Sekiya K, Kinomoto T, Masumoto T, Murata J, Urabe M, Kai Y, Takada R, Morishima T, Shigekawa M, Ohkawa K.   +13 more
europepmc   +1 more source

Gut microbiota-derived extracellular vesicles: bridging microbial-host crosstalk in metabolic disorders. [PDF]

Cell Commun Signal
Ma K, Zhang Q, Jin Z, Hao R, Sun X, Zhou L, Li M.   +6 more
europepmc   +1 more source

Prognostic factors in first-line atezolizumab-bevacizumab treatment of intermediate or advanced hepatocellular carcinoma. [PDF]

PLoS One
Gu K, Kang TW, Shin J, Sinn DH, Goh MJ, Hong JY, Chi S.   +6 more
europepmc   +1 more source

Differential Tumor Response and Conversion Outcomes Associated with First-Line Biologic Strategies in Liver-Limited <i>RAS</i> Wild-Type Metastatic Colorectal Cancer. [PDF]

Oncol Res
Chiang SW, Chen MC, Lin CL, Huang YL, Chiang FF, Yang SF.   +5 more
europepmc   +1 more source